发现了由道元力学模拟指导的新型抗阻力AR对手
Haiyi Chen1,2,3, Yuxin Zhou1, Xinyue Wang1
1College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|March 14, 2024
概括
新的研究揭示了雄激素受体 (AR) 抗剂如何破坏前列腺癌 (PCa) 细胞功能,为克服药物耐药性提供了一种策略. 这项研究确定了对抗抗性突变有效的新型AR抗剂.
科学领域:
- 分子生物学分子生物学
- 计算化学是一种计算化学.
- 在瘤学瘤学.
背景情况:
- 雄激素受体 (AR) 抗剂对于前列腺癌 (PCa) 治疗至关重要.
- 药物耐药性显著限制了当前AR抗剂的长期疗效.
- 了解AR抗体相互作用对于开发下一代疗法至关重要.
研究的目的:
- 阐明AR抗体调节AR的分子机制.
- 为了确定对抗药物耐药前列腺癌有效的新型AR抗剂.
- 为开发新的抗耐药AR抗剂提供一种合理的战略.
主要方法:
- 道元动力学模拟用于研究AR抗剂的结合机制.
- 生物测试以验证观察到的疏水性接触的功能重要性.
- 基于对接的虚拟选,以识别新的AR抗候选人.
主要成果:
- 证明AR抗体的结合破坏了AR-11和AR连体结合域 (AR-LBD) 内的关键水性接触.
- 这种干扰影响了AR联体结合口袋 (AR-LBP),激活功能2 (AF2) 和结合功能3 (BF3) 之间的通信.
- 达洛胺证明了对抗抗性AR突变的有效性,虚拟查发现了三种新的强效对抗剂.
结论:
- 疏水性接触对AR功能至关重要,它们的破坏是AR对抗的关键机制.
- 达洛胺的独特结合诱导了对抗性结构,为新药设计提供了一个模板.
- 这项研究提出了一种新的,合理的策略,用于开发AR抗剂,以克服前列腺癌中药物耐药性.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.2K
相关概念视频
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
Combined Effects of Drugs: Antagonism
8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
